drugset / Trial / NCT01893788
Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to determine which treatment will be more effective to reduce left ventricular mass in hypertensive patients with left ventricular hypertrophy comparing aliskiren and eplerenone.
Timeline
- Start
- 2013-04
- Primary completion
- 2016-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aliskiren | Small molecule | 150 mg | — |
| Comparator | Aliskiren | Small molecule | 300 mg | — |
| Comparator | Eplerenone | Unknown | 50 mg | — |
| Comparator | Eplerenone | Unknown | 100 mg | — |